Osaka, Japan

Tatsuji Seki

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 72(Granted Patents)


Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Tatsuji Seki

Introduction

Tatsuji Seki is a renowned inventor based in Osaka, Japan, with a remarkable track record of seven patents to his name. His contributions to the field of biotechnology, particularly in glycoprotein production, make him a significant figure in contemporary scientific research.

Latest Patents

Tatsuji Seki's latest patents focus on advanced methods for producing glycoproteins with human-type sugar chains in transgenic plant cells. One noteworthy patent outlines a method for co-expressing galactosyltransferase and a glycoprotein in a transformed plant cell. This intricate approach involves several steps: introducing specific genes into a plant cell, culturing the cell, isolating the glycoprotein from the culture medium, and modifying it through the addition of a sialic acid residue. His innovations promise advancements in the production of glycoproteins essential for various therapeutic applications.

Career Highlights

Throughout his career, Tatsuji Seki has significantly contributed to the biotechnological landscape, working with notable organizations such as Phyton Holdings and DFB Biotech, Inc. His work is characterized by a blend of scientific rigor and innovative thinking, aimed at improving the methodologies for glycoprotein expression and isolation.

Collaborations

In his journey, Tatsuji Seki has collaborated with prominent scientists, including Kazuhito Fujiyama and Toshiomi Yoshida. These partnerships have led to the enrichment of his research, exchanging ideas that have further propelled advancements in their shared field.

Conclusion

Tatsuji Seki's inventive spirit and dedication to biotechnology have resulted in significant advancements in the production of glycoproteins with human-type sugar chains. His latest patents showcase a commitment to enhancing medical and biotechnological possibilities, solidifying his status as an esteemed inventor in Osaka, Japan.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…